Biotech | March 14, 2022
Clarivate deals report highlights emerging trends in biopharma deal-making
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
The award recognizes and supports promising women scientists
Use of Wipro Holmes Artificial Intelligence capabilities will lead to faster development of advanced therapeutics, improving patient outcomes
The RI investment comes on the back of three other recently completed transactions in Malaysia and Singapore in the last two months
Expanding the Applied Biosystems portfolio with the latest generation of innovative, mid-throughput genetic analyzers
The large-scale production of PhytoChol in Hanau, Germany, will meet an increased market demand for cholesterol
The Genome Valley region has played a pivotal role in fostering the life science industry and the state government has always supported its growth
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
The investment in Indian clinical technology expertise in Hyderabad comes amid the clinical trials sector's move towards decentralised trials
The grants are expected to be received over the next three years, commencing March 2022
Subscribe To Our Newsletter & Stay Updated
